Dr Paul Aurora
Dr Paul Aurora was born in London, and had all his schooling and medical training in the UK.
He first worked as a junior doctor at Great Ormond Street Hospital (GOSH) in 1993, and has been consultant since 2002. He is fully trained in all aspects of paediatric respiratory medicine, but his NHS practice focuses on rare, complex, and severe lung diseases, for which he provides advice to colleagues throughout the UK. He is a recognised international authority on interstitial lung diseases, complex multisystem disorders, lung transplantation, and lung function testing in children of all ages, and frequently contributes to the work of international scientific societies.
He is clinical lead for the following areas:
- Lung Function Laboratory
- Interstitial Lung Disease Programme
- Clinical Research
- Education and Training
- Observers and Visitors Programme
Dr Aurora places great emphasis on informing parents about all aspects of their child’s care and ensuring that they are able to make informed decisions about treatment.
In addition to his clinical work Dr Aurora places great emphasis on teaching both junior and senior colleagues. He is the educational lead for respiratory medicine at GOSH, runs the South East England teaching programme for this subspecialty, organised and chaired a European Sleep Course in 2013, is co-organiser of the annual Update in Paediatric Respiratory Medicine Course, and previously had great input into organising the European Respiratory Society Annual Conference.
Dr Aurora has given more than 30 invited lectures at major meetings in the five years. Most have been in Europe or North America, but Dr Aurora has also been an invited speaker at Pedicon (Indian National Paediatric Conference) in 2015, on the topic of primary ciliary dyskinesia, the 2nd Saudi Pediatric Pulmonology Association Annual Conference in 2016, on the topic of childhood interstitial lung disease (chILD), and the 3rd International Paediatric Medical Congress in Dubai in 2017, on the topic of stem cell transplantation. Through his teaching and advocacy Dr Aurora has close professional links with colleagues through the world.
Dr Aurora has published more than 100 articles in peer reviewed journals, including 55 between 2009-2014, of which 39 were full-length research reports or data analyses. In the same period he co-chaired/co-authored six evidence based guidelines sponsored by scientific societies in the fields of asthma, cystic fibrosis, and lung transplantation, and wrote five textbook chapters.
- Investigation and treatment of children with complex or rare multisystem disorders
- Leading authority on lung function testing in children of all ages
- Experienced bronchoscopist, and skilled at bronchoscopic biopsy
- Severe or end-stage lung disease
- Rare and congenital lung diseases, including interstitial lung diseases
- Lung transplantation, and respiratory complications of stem cell transplantation
- Cystic fibrosis
- Asthma and preschool wheeze
- Recurrent cough
Investigation and treatment of children with complex or rare multisystem disorders who have chronic or recurrent respiratory symptoms. This particularly applies to children who are requiring multiple hospital or intensive care admissions with respiratory infection or exacerbation. In many cases it has been possible to greatly reduce the amount of hospital care such children require.
- BSc Physiology (London) 1987
- MBBS (London) 1990
- MRCP (London) 1994
- MRCPCH (Foundation member)
- MSc (Masters degree) in Clinical Paediatrics, with distinction (London) 1998
- PhD in Respiratory Physiology (London) 2004
- GMC registered
- Fully Accredited in Paediatrics and Paediatric Respiratory Medicine
Leadership roles in scientific societies:
- Previously Chair of the Paediatric Long Range Planning Committee of the European Respiratory Society
- Previously Chair of scientific group 7.1 of the European Respiratory Society
- Previously Assistant Director of the Registry of the International Society of Heart and Lung Transplantation
Dr Aurora is the academic lead for respiratory medicine at GOSH, and is very active in research. His main research areas are respiratory physiology, lung transplantation and rare lung diseases. He is joint co-ordinator of the London Cystic Fibrosis Collaboration and is also developing new methodology for asthma and interstitial lung disease measurements in young children. The work he has supervised has changed clinical practice nationally and internationally e.g. see consensus documents: Rosenfeld et al Ann Am Thorac Soc. 2013; Stick et al Eur Resp J 2013; Robinson et al Eur Resp J 2013; Hirche et al Pulm Med 2014.
In 2002 Dr Aurora won the European Respiratory Society Award for Paediatric Research in Europe. He was only the 3rd UK researcher to win this award.
News & Publications
Filamin A (FLNA) mutation-A newcomer to the childhood interstitial lung disease (ChILD) classification. Shelmerdine SC, Semple T, Wallis C, Aurora P, Moledina S, Ashworth MT, Owens CM. Pediatr Pulmonol. 2017 Oct;52(10):1306-1315.
Robinson, P.D., Spencer, H., Aurora, P., 2015. Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation. J Heart Lung Transplant.
Stanojevic, S., Bilton, D., McDonald, A., Stocks, J., Aurora, P., Prasad, A., Cole, T.J., Davies, G., 2015. Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis. Eur Respir J.
O'Reilly, R., Kilner, D., Ashworth, M., Aurora, P., 2015. Diffuse lung disease in infants less than 1 year of age: Histopathological diagnoses and clinical outcome. Pediatr Pulmonol.
Harris, K.A., Underwood, A., Kenna, D.T., Brooks, A., Kavaliunaite, E., Kapatai, G., Tewolde, R., Aurora, P., Dixon, G., 2015. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. Clin Infect Dis. 60(7) pp. 1007-16.
Meyer, K.C., Raghu, G., Verleden, G.M., Corris, P.A., Aurora, P., Wilson, K.C., Brozek, J., Glanville, A.R; ISHLT/ATS/ERS BOS Task Force Committee; ISHLT/ATS/ERS BOS Task Force Committee. 2014. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 44(6) pp. 1479-503.
Kansra, S., Aurora, P., 2014. Difficulties mastered are opportunities won: pulmonologist's perspective. Indian Pediatr 51(3) pp. 176-7.
Stanojevic, S., Stocks, J., Bountziouka, V., Aurora, P., Kirkby, J., Bourke, S., Carr, S.B., Gunn, E., Prasad, A., Rosenfeld, M., Bilton, D., 2014. The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry. J Cyst Fibros. 13(3) pp. 319-27.
Thia, L.P., Calder, A., Stocks, J., Bush, A., Owens, C.M., Wallis, C., Young, C., Sullivan, Y., Wade, A., McEwan, A., Brody, A.S; London Cystic Fibrosis Collaboration. 2014. Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age? Thorax. 69(4) pp 320-7.
Nguyen, T.T., Thia, L.P., Hoo, A.F., Bush, A., Aurora, P., Wade, A., Chudleigh, J., Lum, S., Stocks, J.; London Cystic Fibrosis Collaboration 2014. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 69(10) pp. 910-7
Refer your child to Dr Paul Aurora
Use the form below to refer your child for treatment. A member of our team will be in touch within 2 working days.